November 4, 2015 | Dutch pharmaceutical company Mylan will begin trading on the Tel Aviv Stock Exchange (TASE) today, effectively becoming one of the largest companies listed on the Israeli exchange. The decision to dual list on the TASE and the NASDAQ, where the company’s shares are currently traded, is part of Mylan’s takeover strategy in its hostile bid for rival pharmaceutical company Perrigo.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments